Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05575167 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Single or Repeat Zoledronate Versus Alendronate Following Denosumab (EUROpean Denosumab Effects Consolidation Study)

Study acronym: EURODEC
StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Recruiting to Active, Not Recruitingv6 Show 4 more changesShow less
    • Enrollment target: estimated 125 to confirmed 122
    • Primary completion date: Nov 2027 to Jul 2027
    • Site details revised at 9 of 9 sites
    • Collaborators expanded, about 15 words
  2. Primary and study completion dates: Nov 2026 to Nov 2027
    • Study sites: 10 to 9
    v5
  3. Trial status: Not Yet Recruiting to Recruitingv4 Show 4 more changesShow less
    • Primary completion date: Jun 2025 to Nov 2026
    • Study sites: 1 to 10
    • Study completion date: Sep 2025 to Nov 2026
    • Start date changed from estimate of Oct 2023 to Nov 28, 2023
  4. Start date: May 2023 to Oct 2023v3
  5. Start date: Nov 2022 to May 2023v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
A 24-month prospective, open-label, randomized, multicenter, multinational, non-inferiority pragmatic clinical trial evaluating zoledronate single or double infusion versus oral alendronate following denosumab
Trial Details
NCT Number NCT05575167
Lead Sponsor 424 General Military Hospital
Collaborators: Laikο General Hospital, Athens, 251 Hellenic Air Force & VA General Hospital, Campus Bio-Medico University
Conditions
(from sponsor)		 Osteoporosis, Postmenopausal
Related terms Osteoporosis, Postmenopausal
Enrollment 122 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov